StockNews.com initiated coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Free Report) in a research note issued to investors on Saturday. The firm issued a strong-buy rating on the stock. Separately, HC Wainwright cut Taro Pharmaceutical Industries from a buy rating to a neutral rating and set a $43.00 price target for the company. […]
StockNews.com began coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Free Report) in a research report report published on Saturday. The brokerage issued a strong-buy rating on the stock. Separately, HC Wainwright downgraded Taro Pharmaceutical Industries from a buy rating to a neutral rating and set a $43.00 target price for the company. in […]
Taro Pharmaceutical Industries Ltd. (NYSE:TARO – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $40.01 and traded as high as $42.49. Taro Pharmaceutical Industries shares last traded at $42.40, with a volume of 27,051 shares. Analyst Upgrades and Downgrades A number […]
StockNews.com started coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Free Report) in a report published on Sunday morning. The brokerage issued a strong-buy rating on the stock. Separately, HC Wainwright cut shares of Taro Pharmaceutical Industries from a buy rating to a neutral rating and set a $43.00 target price on the stock. […]
StockNews.com assumed coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Free Report) in a research report released on Sunday morning. The firm issued a strong-buy rating on the stock. Separately, HC Wainwright cut Taro Pharmaceutical Industries from a buy rating to a neutral rating and set a $43.00 target price on the stock. in […]